New investments and data scale aim to transform pathology workflows and diagnostic speed

ROCHESTER, Minn. — Mayo Clinic Digital Pathology (MCDP) is advancing efforts to build an integrated innovation ecosystem that supports the future of pathology across clinical care and research. The work reflects Mayo Clinic’s broader digital pathology strategy, including investments in emerging companies, expanded use of digitized pathology data and collaborations designed to improve diagnostic workflows and speed.

As part of this effort, MCDP is collaborating with companies, including Conflux and ViewsML, whose technologies align with its goal of enabling more efficient, scalable and data-informed pathology practices. The initiative is also focused on creating the infrastructure and relationships needed to translate digital pathology innovation into real-world clinical and research impact.

The move reflects growing momentum in the adoption of digital pathology across health systems, as providers seek to address workforce constraints, rising case complexity and demand for faster, more precise diagnoses.

“This commitment reflects Mayo Clinic’s mission to thoughtfully integrate emerging technologies in ways that meaningfully improve patient care,” said Jim Rogers, CEO of Mayo Clinic Digital Pathology. “By advancing digital pathology capabilities, we are enabling our clinicians to deliver faster, more precise insights while also creating new opportunities for research and discovery.”

MCDP is focused on scaling technologies that improve diagnostic accuracy, increase efficiency and support new models of care. Current areas of development and evaluation include AI tools that enhance routine image analysis, improve case-to-slide matching accuracy and reduce reliance on time- and resource-intensive manual processes. Pathologists and clinicians remain responsible for interpreting results and making all clinical decisions related to patient care.

These efforts are part of a broader shift toward software-driven diagnostics and precision medicine, where digital infrastructure and machine learning increasingly play a role in clinical decision-making. While the technologies are still undergoing validation, Mayo Clinic officials say they have the potential to expand access to specialized expertise, accelerate discovery and support more informed treatment decisions.

MCDP’s strategy is anchored by significant internal assets, including a repository of more than 17 million digitized pathology slides and advanced computing capabilities such as the Assisi Cluster. The initiative also connects with Mayo Clinic Laboratories’ global network of more than 3,100 clients across 55+ countries and the Mayo Clinic Platform, which provides data and analytics infrastructure for innovation.

By combining investment, data scale and clinical expertise, Mayo Clinic Digital Pathology aims to position digital pathology as a foundational component of future diagnostics, both within its own system and across the broader healthcare ecosystem.

###

About Mayo Clinic Digital Pathology
Mayo Clinic Digital Pathology advances the global adoption of digital pathology to improve patient care and accelerate medical breakthroughs. It supports innovation in slide digitization, data infrastructure, artificial intelligence and diagnostic tool development, working with internal experts and external partners to build and scale new technologies.

About Mayo Clinic  
Mayo Clinic is a nonprofit organization committed to innovation in clinical practice, education and research, and providing compassion, expertise and answers to everyone who needs healing. Visit the Mayo Clinic News Network for additional Mayo Clinic news.

Media contact:

• Tom Millikin, Mayo Clinic Communications, newsbureau@mayo.org

Related Articles